The 1997 moyer award: Cytokine production in patients with hypertrophic burn scars

Journal of Burn Care and Rehabilitation

Volumn 18, Issue 6, 1997, Pages 477-482

  Polo, M ^b   Ko, F ^b   Busillo, F ^b   Cruse, C W ^b   Krizek, T J ^b   Robson, Martin C ^a  

^a Bay Pines VA Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BURN SCAR; CELL PROLIFERATION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; PATHOGENESIS;

EID: 0030701910     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199711000-00002     Document Type: Article

References (25)

1. Helm PA. Burn rehabilitation: dimensions of the problem. Clin Plast Surg 1976;57:207-12.
2. Linares HA, Larson DL. Early differential diagnosis between hypertrophic and nonhypertrophic healing. J Invest Dermatol 1974;62:514-6.
3. Wahl SM, Wahl LM, McCarthy JB. Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol 1978;121:942-6.
4. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12:17-23.
5. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, et al. Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84:5788-92.
6. Duncan MR, Berman B. γ-interferon is the lymphokine and β-interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985;162:516-27.
7. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-92.
8. McCauley RL, Chopra V, Li YY, Herndon DN, Robson MC. Altered cytokine production in black patients with keloids. J Clin Immunol 1992;12:300-8.
9. Brody GS, Peng STJ, Landel RF. The etiology of hypertrophic scar contracture: another view. Plast Reconstr Surg 1981;67: 673-84.
10. Cohen IK, McCoy BJ. The biology and control of surface overhealing. World J Surg 1980;4:289-95.
11. Constantian MB. Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients. Ann Surg 1978;188:209-14.
12. Oluwasanmi JO, Lucas DO, Chvapil M. Effect of a concurrent immune response on the collagen synthesis around implanted ivalon sponges. Plast Reconstr Surg 1976;58:601-7.
13. Neuner P, Urbani A, Trautinger F, Moler A, Kirnbauer R, Kapp A, et al. Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol 1991;97:27-33.
14. Elias JA, Jimenez SA, Freundlich B. Recombinant gamma, alpha and beta interferon regulation of lung fibroblast proliferation. Am Rev Resp Dis 1987;135:62-5.
15. Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1984;74:1112-6.
16. Berman B, Duncan MR Short term keloid treatment m vivo with human interferon alpha-2b results in a selective and persistent normalization of keloidal collagen, glycosaminoglycan and collagenase production in vitro. J Am Acad Dermatol 1989;21:694-702.
17. Ignotz RA, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261:4337-45.
18. Bassols A, Massague J. Transforming growth factor-β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem 1988; 263:3039-45.
19. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angel P, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. Eur Mol Biol Organ J 1987;6:1899-904.
20. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992;90: 1-7.
21. Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K. The role of transforming growth factor beta in Dupuytren's disease. J Hand Surg [Am] 1996;21A:210-5.
22. 1 ,2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994;107:1137-57.
23. Ghahary A, Shen YJ, Scott PG, Gong Y, Tredget EE. Enhanced expression of mRNA for transforming growth factor-β, type I and type III procollagen in human post-burn hypertrophic scar tissues. J Lab Clin Med 1993;122:465-73.
24. Linares HA. Proteoglycan-lymphocyte association in the development of hypertrophic scars. Burns 1990;16:21-4.
25. Kulozik M, Hogg A, Lankat-Buttgercit B, Krieg T. Colocalization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 1990;86:917-22